Research and publish the best content.
Get Started for FREE
Sign up with Facebook Sign up with X
I don't have a Facebook or a X account
Already have an account: Login
Cancer Contribution
37.4K views |
+0 today
 Your new post is loading...
Your new post is loading...
Scoop.it!
Atteinte d'une tumeur à un ovaire, cette Franco-Américaine ne doit sa survie qu'à son carnet d'adresses. 
Scoop.it!
L’enquête montre des « progrès significatifs » dans la durée de vie des patients atteints d’un cancer du sein, de la prostate ou du côlon-rectum.
Scoop.it!
Le premier site collaboratif francophone dédié au cancer. Débats, forums, actualités, enquêtes, sondages, rencontres >> témoignez, participez, contribuez.
Scoop.it!
FUMER TUE, contrairement à ce que la publicité nous laissait croire au siècle dernier.
Scoop.it!
Le premier site collaboratif francophone dédié au cancer. Débats, forums, actualités, enquêtes, sondages, rencontres >> témoignez, participez, contribuez.
Giovanna Marsico's insight:
Les propositions issues de la plateforme Cancer Contribution pour le Plan Cancer 3
Scoop.it!
Salvatore a un cancer du cerveau. Ses données médicales ne sont accessibles qu'en format fermé, dans un dossier disponible pour la seule équipe qui suit son parcours de soins. Salvatore connaît le web, il est ingénieur, artiste, hacker et IxD designer...il ne se laisse pas faire. Son dossier informatique s'ouvre sous ses mains, il est traduit en format accessible et se transforme en prototype tout personnel d’Open Data.
"Dans la seule journée d'aujourd’hui j'ai partagé mes données avec 3 médecins, deux d'entre eux m'on déjà répondu.
Celle-ci est une CURE, mon OPEN SOURCE CURE.
Le mot CURE réponde à des concepts différents selon les cultures. Certaines cures sont pour le corps, d'autres pour l'esprit, d'autres pour la communication.
Prenez les informations sur ma pathologie, si cela vous tente, et donnez moi une CURE: sous forme de Vidéo, d'œuvre d'art, une carte, un texte, une poésie, un jeu, autrement essayez à comprendre comment résoudre mon problème de santé.
Artistes, designers, hackers, chercheurs, patients (n.d.r.), médecins, photographes, vidéastes, musiciens, écrivains...Tout le monde peut m'offrir une cure.
Vous êtes tous invités »
|
Scoop.it!
Cancer de la thyroïde : la propagation observée dans les pays développés due à un dépistage excessif
Dans une étude publiée dans la revue The New England Journal of Medicine, le Centre international de la recherche sur le cancer (CIRC/IARC) basé à Lyon évalue à plus de 470.000 femmes et 90.00
Scoop.it!
- Assurer en priorité une couverture régionale par les HAD, de l’activité de chimiothérapie pour la prise en charge en hématologie, les traitements administrés par voie sous-cutanée, et concernant les [...]...
Scoop.it!
Le premier site collaboratif francophone dédié au cancer. Débats, forums, actualités, enquêtes, sondages, rencontres >> témoignez, participez, contribuez.
Scoop.it!
New tools for analyzing genes are allowing doctors to personalize treatment for some lung cancer patients. Imagine your doctor being able to scan your DNA from a biopsy and pinpoint the medicine that will work best for you. This type of high-tech approach is a clinical reality for advanced lung cancer at The Ohio State Comprehensive Cancer Center – Arthur G. James Cancer Hospital and Richard J. Solove Research Institute (OSUCCC – James). The technology, known as next generation "multiplex" gene sequencing, analyzes 50-plus genes in DNA extracted from a tumor biopsy for particular genetic mutations. Previous technology required pathologists to analyze one mutation per tube in a sequencing reaction, but next-generation genome sequencing assesses more than 2,500 mutations in a single reaction. Knowing which mutations are present in lung tumors can help doctors tailor a patient's treatment to the unique genetic features present in his or her cancer cells. The knowledge can also help in the development of new drugs that target previously unrecognized gene mutations in lung tumors. I often compare these genes to the gas pedal in a car — when activated, these genes make the cancer grow. By breaking the linkage between the gas pedal and the motor (or interfering with these "driver" mutations) with specific targeted drugs, doctors can stop this growth and often make the cancer shrink. That's especially important in lung cancer because the majority of patients with this disease are diagnosed in the later stages, meaning it's important to start effective therapies quickly. For example, a patient could be given a standard chemotherapy and expect a 25- to 30- percent response rate/shrinkage of a tumor. But if the treatment team knows that a patient has a mutation in a gene called EGFR, we can offer him or her a pill (erlotinib and afatinib are approved for this use in the United States), which has a 75-percent response rate and fewer side effects. Gene sequencing is now considered the standard of care for stage-4 lung cancer patients at The OSUCCC – James and a handful of other centers across the United States — and several clinical trials evaluating molecular targeted therapies for patients with stage-3 lung cancers will soon start at The OSUCCC – James. Lung cancer remains the number one cause of cancer death in the United States, and in the world, among both men and women. More than 200,000 cases are diagnosed annually in the United States. Each year during the month of November, physicians and others observe lung cancer awareness month, which sheds light on this terrible disease. Via nrip
Scoop.it!
Depression is a serious illness that can have a major impact on an individual's quality of life. In fact, 15-25% of people diagnosed with cancer also suffer from depression. This is more than double that of the general population. Via Marie Ennis-O'Connor
Giovanna Marsico's insight:
La dépression est une pathologie sérieuse, qui génère un impact important sulla qualité de vie des personnes qui en souffrent. Les études montrent aujourd'hui que les personnes malades de cancer souffrent souvant aussi de depression, bien plus que la population générale. Cela n'est pas neutre quand on sait que l'état mental et le bien-être peuvent conditionner le succès des traitements.
Giovanna Marsico's comment,
October 3, 2013 12:17 PM
Oui, il parle de la dépression comme effets collatéral de la maladie et des traitements, non comme facteur oncogène.
Heather Swift's curator insight,
October 9, 2013 8:40 PM
Depression is a serious illness that can have a major impact on an individual's quality of life. In fact, 15-25% of people diagnosed with cancer also suffer from depression. This is more than double that of the general population.
Scoop.it!
A daily low dose of aspirin could potentially combat a variety of cancers, according to a series of studies published in the medical journal The Lancet. Ray ... Via Graham Player Ph.D.
Graham Player Ph.D.'s curator insight,
June 22, 2013 12:26 PM
This is an older video that gives you a better understanding of aspirin and its possible cancer benefit. It has been known for many years that aspirin can lower risk for cancer.
Scoop.it!
Patients with late-stage lung and colon cancer often don't realize that chemotherapy will not cure them, a new study finds.
|
